Biopharmaceutical research companies are conducting or have conducted more than 1,200 clinical trials of new medicines in collaboration with the state’s clinical research centers and hospitals (2004 to present).
In 2017 alone, there were 133 active industry-sponsored clinical trials in Montana, with an estimated enrollment of 3,242 Montana residents. The investment at clinical trial sites was more than $153 million and the estimated total economic impact was more than $394 million.
“Clinical trials in Montana allow patients access to cutting edge research, treatment and quality care. In addition to the human impact, they also have a significant economic impact that benefits all Montanans. Biopharmaceutical research companies support more than 4,256 direct jobs across Montana, while generating millions in economic activity in the state. These numbers reflect the fact that the clinical research not only shapes the future of disease treatment, but also, employs Montanans and stimulates our economy.” – Sharon Peterson Montana BioScience Alliance